Patient Alert: Losartan Tablet Recall

January 10, 2019


HealthTeam Pharmacies received notice from its distributor of a voluntary recall of several lot numbers of Losartan. This product recall is due to the detection of an unexpected impurity. To date, there are no reports of any harm to patients taking this drug subjected to this recall. Not all products containing Losartan have been recalled.

Losartan is used to treat hypertension, heart failure and nephropathy in type 2 diabetic patients. 

MSU HealthTeam Pharmacies will be notifying its patients in the following manner:

  • Communicating in person to all individuals prescribed losartan, who present at our pharmacies.
  • Phone calls to MSU HealthTeam pharmacy patients dispensed losartan during the manufactured ship date, as identified by a report from our pharmacy software.
  • Letter to above MSU HealthTeam pharmacy patients not reached by phone call.

Patients do not need to wait for us to notify them. If you have questions, please call one of our pharmacy locations and speak to a staff member. 

Olin Pharmacy 517-353-9165

Clinical Center Pharmacy 517-353-4930


In alignment with FDA guidelines, HealthTeam Pharmacies is recommending all patients:

  • Continue taking the recalled medication until you have an alternative treatment if losartan is still part of your treatment, because risk of harm to your health may be higher if the treatment is stopped immediately without any alternative treatment.
  • Review their losartan prescription bottle label against the official product recall list for the product name, manufacturer details and batch or lot number on the bottle. Contact the dispensing pharmacy if the information is not on the bottle.
  • If you have a recalled prescription, contact your pharmacist or your provider who can advise you about an alternative treatment.

The safety of all MSU patients, faculty and staff is our primary concern. This information contains what we currently know about the Losartan recall from the FDA. View the full recall notice.

Any adverse reactions or quality problems experienced with this product may be reported directly to the manufacturer (Torrent 1-800-912-9561) or the FDA’s MedWatch Adverse Event Reporting program (